Literature DB >> 29589398

Pathogenesis of polymyalgia rheumatica.

G Guggino1, A Ferrante, F Macaluso, G Triolo, F Ciccia.   

Abstract

Polymyalgia rheumatica (PMR) is a chronic, inflammatory disorder of unknown cause, almost exclusively occurring in people aged over 50 and often associated with giant cell arteritis. The evidence that PMR occurs almost exclusively in individuals aged over 50 may indicate that age-related immune alterations in genetically predisposed subjects contribute to development of the disease. Several infectious agents have been investigated as possible triggers of PMR even though the results are inconclusive. Activation of the innate and adaptive immune systems has been proved in PMR patients as demonstrated by the activation of dendritic cells and monocytes/macrophages and the altered balance between Th17 and Treg cells. Disturbed B cell distribution and function have been also demonstrated in PMR patients suggesting a pathogenesis more complex than previously imagined. In this review we will discuss the recent findings regarding the pathogenesis of PMR.

Entities:  

Keywords:  Adaptive immunity; Innate immunity; Pathogenesis.; Polymyalgia rheumatica

Mesh:

Substances:

Year:  2018        PMID: 29589398     DOI: 10.4081/reumatismo.2018.1048

Source DB:  PubMed          Journal:  Reumatismo        ISSN: 0048-7449


  9 in total

Review 1.  Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following COVID-19 vaccines: working notes from a narrative review of published literature.

Authors:  Ciro Manzo; Alberto Castagna; Marco Isetta
Journal:  Reumatologia       Date:  2022-05-18

Review 2.  Pathogenesis, Diagnosis and Management of Polymyalgia Rheumatica.

Authors:  Dario Camellino; Andrea Giusti; Giuseppe Girasole; Gerolamo Bianchi; Christian Dejaco
Journal:  Drugs Aging       Date:  2019-11       Impact factor: 3.923

3.  Polymyalgia rheumatica: an autoinflammatory disorder?

Authors:  Alberto Floris; Matteo Piga; Alberto Cauli; Carlo Salvarani; Alessandro Mathieu
Journal:  RMD Open       Date:  2018-06-04

4.  Incidence and Prevalence of Polymyalgia Rheumatica (PMR): The Importance of the Epidemiological Context. The Italian Case.

Authors:  Ciro Manzo
Journal:  Med Sci (Basel)       Date:  2019-08-30

Review 5.  Neck pain: global epidemiology, trends and risk factors.

Authors:  Somaye Kazeminasab; Seyed Aria Nejadghaderi; Parastoo Amiri; Hojjat Pourfathi; Mostafa Araj-Khodaei; Mark J M Sullman; Ali-Asghar Kolahi; Saeid Safiri
Journal:  BMC Musculoskelet Disord       Date:  2022-01-03       Impact factor: 2.362

6.  Retrospective Analysis of Factors Associated with Fracture in 714 Patients with Polymyalgia Rheumatica.

Authors:  Rajiv Ark; Khojasta Talash; Marwan Bukhari
Journal:  Int J Rheumatol       Date:  2022-02-12

Review 7.  Giant Cell Arteritis: A Case-Based Narrative Review of the Literature.

Authors:  Davis C Thomas; Prisly Thomas; Deep P Pillai; Dahlia Joseph; Upasana Lingaiah; Blessy C Mathai; Anjali Ravi; Surabhi Chhabra; Priyanka Kodaganallur Pitchumani
Journal:  Curr Pain Headache Rep       Date:  2022-09-03

8.  Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica.

Authors:  Yannick van Sleen; Jacoba C Graver; Wayel H Abdulahad; Kornelis S M van der Geest; Annemieke M H Boots; Maria Sandovici; Elisabeth Brouwer
Journal:  Front Immunol       Date:  2019-08-22       Impact factor: 7.561

9.  The Role of Tumor Necrosis Factor Alpha Antagonists (Anti TNF-α) in Personalized Treatment of Patients with Isolated Polymyalgia Rheumatica (PMR): Past and Possible Future Scenarios.

Authors:  Ciro Manzo; Elvis Hysa; Alberto Castagna; Marco Isetta
Journal:  J Pers Med       Date:  2022-02-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.